Publications by authors named "Matteo Maule"

Claim this Profile
W
When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications.
Marco Caminati, Andrea Portacci, Francesca Cefaloni, Antonella Loperfido, Matteo Maule

Expert Rev Respir Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fungal-Driven Airways Dis-Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities and Differences. An EAACI Task Force Report.
Marco Caminati, Isabella Annesi-Maesano, Wojciech Feleszko, Giuseppe Guida, Christer Janson, Matteo Maule

Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Traditional biomarkers and clinical hallmarks in the frame of epithelial driven airways inflammation.
Marco Caminati, Marco Zurlo, Giuseppe Guida, Francesca Bertolini, Stefano Levra, Matteo Maule

Expert Rev Respir Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.
Paolo Delvino, Luca Quartuccio, Joanna C Robson, Virginia V Ferretti, Catherine Klersy, Matteo Maule

Rheumatology (Oxford)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up.
Laura Pini, Marco Caminati, Matteo Maule, Diego Bagnasco, Bianca Beghè

Respir Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life Snapshot.
Marco Caminati, Matteo Maule, Diego Bagnasco, Bianca Beghè, Fulvio Braido

J Allergy Clin Immunol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study.
Irene Mattioli, Maria Letizia Urban, Roberto Padoan, Aladdin J Mohammad, Carlo Salvarani, Matteo Maule

J Autoimmun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of body anthropometry in severe asthmatic patients: Evidences from the Severe Asthma Network in Italy (SANI) registry.
Erminia Ridolo, Martina Ottoni, Francesca Nicoletta, Francesca Locatelli, Luigi Martinelli, Matteo Maule

World Allergy Organ J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation.
Naila Arif Cheema, Annalisa Castagna, Francesca Ambrosani, Giuseppe Argentino, Simonetta Friso, Matteo Maule

Cells· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort.
Marco Caminati, Alessandro Marcon, Rachele Vaia, Gianenrico Senna, Matteo Maule

World Allergy Organ J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC).
Marco Caminati, Luisa Brussino, Matilde Carlucci, Palma Carlucci, Lucia Federica Carpagnano, Matteo Maule

Cells· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, management and therapeutic options for eosinophilic esophagitis.
Marco Caminati, Gianenrico Senna, Matteo Maule, Antonio Di Sabatino, Carlo Maria Rossi

Curr Opin Allergy Clin Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study.
Laura Pini, Diego Bagnasco, Bianca Beghè, Fulvio Braido, Paolo Cameli, Matteo Maule

J Clin Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma.
Matteo Maule, Joana Vitte, Francesca Ambrosani, Marco Caminati

Curr Opin Allergy Clin Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis.
Marco Caminati, Elena Scarpieri, Matteo Maule, Patrick Pinter, Michele Schiappoli

Rheumatology (Oxford)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group.
Marco Caminati, Angelo Fassio, Federico Alberici, Chiara Baldini, Federica Bello, Matteo Maule

Allergy· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective.
Marco Caminati, Matteo Maule, Roberto Benoni, Diego Bagnasco, Bianca Beghè

Biomedicines· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance.
Marco Caminati, Matteo Maule, Roberto Benoni, Claudio Micheletto, Cristina Tecchio

Orphanet J Rare Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach.
Matteo Maule, Bianca Olivieri, Gabriella Guarnieri, Lucia De Franceschi, Nicola Martinelli

J Clin Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologics for eosinophilic granulomatosis with polyangiitis.
Marco Caminati, Matteo Maule, Federica Bello, Giacomo Emmi

Curr Opin Allergy Clin Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective.
Marco Caminati, Alessandro Marcon, Gabriella Guarnieri, Jessica Miotti, Diego Bagnasco, Matteo Maule

J Clin Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and Management of Allergic Rhinitis in Asthmatic Children.
Laura Tenero, Rachele Vaia, Giuliana Ferrante, Matteo Maule, Laura Venditto

J Asthma Allergy· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Take on Systemic Sclerosis Patients' Vaccination Recommendations.
Giuseppe Murdaca, Giovanni Noberasco, Dario Olobardi, Claudio Lunardi, Matteo Maule

Vaccines (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?".
Marco Caminati, Ernesto Crisafulli, Claudio Lunardi, Claudio Micheletto, Giuliana Festi, Matteo Maule

J Allergy Clin Immunol Pract· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma: reply.
Marco Caminati, Matteo Maule, Francesca Nalin, Gianenrico Senna, Claudio Lunardi

Rheumatology (Oxford)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis